Here’s
something interesting from the nice people at Oncology Central – a novel
marker (IPS-E) gives a clearer
indication of when active treatment for CLL might best be started.
This is (supposed to be) a reflective diary by a (not very) anonymous biomedical scientist who works somewhere in the south of England. One day this diary may well be submitted to the Health and Care Professions Council as evidence of ongoing continual professional development....
No comments:
Post a Comment